Does NIVOLUMAB Cause Tenderness? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Tenderness have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
37
Reports of Tenderness with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Tenderness From NIVOLUMAB?
Of the 37 reports, 13 (35.1%) required hospitalization, and 2 (5.4%) were considered life-threatening.
Is Tenderness Listed in the Official Label?
Yes, Tenderness is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Tenderness?
METHOTREXATE (853)
ETANERCEPT (615)
TOFACITINIB (604)
ADALIMUMAB (561)
SECUKINUMAB (484)
SULFASALAZINE (294)
HYDROXYCHLOROQUINE (289)
PREDNISONE (278)
RITUXIMAB (262)
DICLOFENAC (258)
Which NIVOLUMAB Alternatives Have Lower Tenderness Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE